Orbimed Advisors - AERPIO PHARMACEUTICALS INC ownership

AERPIO PHARMACEUTICALS INC's ticker is ARPO and the CUSIP is 00810B105. A total of 1 filers reported holding AERPIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of AERPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$8,778,000
+31.0%
5,193,9460.0%0.09%
+41.3%
Q1 2021$6,700,000
+31.6%
5,193,9460.0%0.06%
+40.0%
Q4 2020$5,090,000
-34.7%
5,193,9460.0%0.04%
-54.1%
Q3 2020$7,791,000
+20.0%
5,193,9460.0%0.10%
+7.7%
Q2 2020$6,492,000
+127.3%
5,193,9460.0%0.09%
+89.6%
Q1 2020$2,856,000
-11.8%
5,193,9460.0%0.05%
+4.3%
Q4 2019$3,238,000
-8.3%
5,193,9460.0%0.05%
-31.3%
Q3 2019$3,531,000
-25.3%
5,193,9460.0%0.07%
-8.2%
Q2 2019$4,726,000
+1.0%
5,193,9460.0%0.07%
+1.4%
Q1 2019$4,680,000
-47.0%
5,193,9460.0%0.07%
-55.8%
Q4 2018$8,830,000
-45.0%
5,193,9460.0%0.16%
-15.5%
Q3 2018$16,049,000
-25.5%
5,193,9460.0%0.19%
-24.9%
Q2 2018$21,555,0005,193,9460.26%
Other shareholders

There were no reported owners of AERPIO PHARMACEUTICALS INC in Q3 2021.

NameSharesValueWeighting ↓
View complete list of AERPIO PHARMACEUTICALS INC shareholders